To our knowledge, this is the first demonstration of an approach that combines bioinformatics and cell-based tools to successfully identify immunogenic neo-antigens presented by human pancreatic cancer cells on MHC class II molecules. The gene discussed is HLA-C; the disease is familial pancreatic carcinoma.